Stek advises Abacus on its acquisition of Pluripharm

Danish pharmaceutical supplier Abacus Medicine A/S has acquired Dutch pharmaceutical wholesaler Pluripharm Group. The group is one of four leading pharmaceutical wholesalers in the Netherlands with a full line of medicines, medical devices and services. Stek advised on the acquisition including the merger control proceeding before the Dutch Competition Authority.

Please click here for the press release.

This might also interest you

Stek advised private equity fund Egeria on the sale of Dynniq Energy to Heijmans

Stek successful for heat supply sector in appeal against tariff regulation

Stek advises Enexis Group on the sale of Fudura to PGGM Infrastructure Fund and DIF Capital Partners